RSV Antibiotic Drivers And Resource-use
NCT06977971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209
Last updated 2025-05-23
Summary
This study retrospectively evaluated the clinical, laboratory, and radiologic factors that influence the decision to prescribe antibiotics in children under 2 years of age hospitalized with RSV-positive acute lower respiratory tract infections. The study also examined the economic impact of antibiotic use in these patients. The goal is to improve clinical decision-making and reduce unnecessary antibiotic exposure in children with viral infections.
Conditions
- Respiratory Syncytial Virus Infections
- Antibiotic Stewardship in Community Hospitals
Sponsors & Collaborators
-
Dr. Behcet Uz Children's Hospital
lead OTHER
Principal Investigators
-
Burcu Büşra B Acar, Pediatric Cardiology Fellow · Ege University
-
Burcu Büşra B Acar, Pediatric Cardiology Fellow · Ege University Faculty of Medicine, Department of Pediatric Cardiology
Eligibility
- Min Age
- 1 Month
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-01
- Primary Completion
- 2021-04-01
- Completion
- 2023-10-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants
NCT06746051 ·Status: COMPLETED
-
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
NCT06881953 ·Status: RECRUITING
-
Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants
NCT04144816 ·Status: UNKNOWN
-
Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy
NCT03096574 ·Status: UNKNOWN
-
Disease Burden of RSV
NCT05506670 ·Status: COMPLETED ·Phase: NA
-
Impact of the Covid-19 on RSV
NCT05348616 ·Status: UNKNOWN
-
Infant RSV Infections and Health-related Quality of Life of Families
NCT05550545 ·Status: UNKNOWN
-
Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers
NCT01563692 ·Status: COMPLETED
-
CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
NCT06640387 ·Status: ACTIVE_NOT_RECRUITING
-
An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants
NCT02273882 ·Status: COMPLETED
-
Evaluation of Newborns Presenting With Suspected COVID 19
NCT04519307 ·Status: UNKNOWN
-
Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands
NCT06318936 ·Status: RECRUITING
-
Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source
NCT02179398 ·Status: COMPLETED ·Phase: NA
-
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
NCT00983606 ·Status: COMPLETED
-
Understanding RSV: Severe Disease and the Long Term Consequences
NCT03756766 ·Status: ACTIVE_NOT_RECRUITING
-
Transplacental Transmission of RSV (TTRSV)
NCT05443607 ·Status: ACTIVE_NOT_RECRUITING
-
TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit
NCT00263900 ·Status: COMPLETED ·Phase: NA
-
Infection With Respiratory Syncytial Virus in Infants
NCT04925310 ·Status: UNKNOWN
-
An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates
NCT00760279 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon
NCT05348655 ·Status: UNKNOWN
-
Early Antibiotic Therapy and Vaccinations in Preterm Infants
NCT05563753 ·Status: UNKNOWN
-
Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.
NCT06389383 ·Status: COMPLETED ·Phase: NA
-
Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates
NCT00599053 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
NCT04528251 ·Status: UNKNOWN
-
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02527681 ·Status: TERMINATED ·Phase: PHASE1